PubRank

Martin C Mihm

Author PubWeight™ 179.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009 23.08
2 Melanoma. N Engl J Med 2006 8.80
3 Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A 2003 5.49
4 Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 2008 4.43
5 Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012 4.04
6 Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004 3.43
7 Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003 2.81
8 De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol 2005 2.38
9 An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature 2012 2.35
10 Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010 2.30
11 Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004 2.29
12 Pyoderma gangrenosum: a review. J Cutan Pathol 2003 2.23
13 Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol 2005 2.22
14 Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 2005 2.12
15 Unusual variants of malignant melanoma. Mod Pathol 2006 1.93
16 Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 2011 1.78
17 Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 2009 1.74
18 Cutaneous vasculitis: a review. J Cutan Pathol 2003 1.74
19 Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol 2005 1.71
20 State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol 2010 1.68
21 EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009 1.68
22 Pigmented epithelioid melanocytoma: report of first Japanese cases previously diagnosed as cellular blue nevus. J Cutan Pathol 2009 1.48
23 Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res 2010 1.47
24 Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol 2003 1.42
25 Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A 2009 1.34
26 Current concepts of metastasis in melanoma. Expert Rev Dermatol 2008 1.34
27 PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol 2003 1.33
28 Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res 2008 1.29
29 The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol 2008 1.28
30 Malignant adnexal neoplasms. Mod Pathol 2006 1.26
31 Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med 2010 1.21
32 SOX2 contributes to melanoma cell invasion. Lab Invest 2011 1.21
33 Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer 2007 1.18
34 Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. J Hematol Oncol 2011 1.18
35 Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 2005 1.17
36 Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med 2008 1.14
37 Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol 2014 1.12
38 Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol 2011 1.11
39 Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004 1.10
40 Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol 2008 1.10
41 Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 2006 1.09
42 Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol 2002 1.08
43 Drug-induced linear IgA bullous dermatosis. J Dermatol 2005 1.07
44 A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011 1.06
45 De novo intraepidermal epithelioid melanocytic dysplasia: an emerging entity. J Cutan Pathol 2009 1.06
46 Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol 2009 1.06
47 Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol 2010 1.04
48 The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003 1.03
49 Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol 2009 1.03
50 AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol 2011 1.02
51 Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009 1.02
52 Markers and tissue resources for melanoma: meeting report. Cancer Res 2006 1.01
53 Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One 2012 1.01
54 Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol 2008 1.01
55 Molecular mechanisms of metastasis. Cancer Metastasis Rev 2006 1.00
56 Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) 2013 0.99
57 Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol 2014 0.99
58 Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol 2011 0.99
59 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med 2004 0.96
60 Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 2007 0.96
61 Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med 2012 0.96
62 Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 2006 0.95
63 Interface dermatitis. Arch Pathol Lab Med 2008 0.95
64 Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin North Am 2009 0.95
65 Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol 2002 0.94
66 Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med 2012 0.93
67 Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas. Am J Surg Pathol 2005 0.93
68 Increased diagnosis of thin superficial spreading melanomas: A 20-year study. J Am Acad Dermatol 2011 0.93
69 Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration. Lasers Surg Med 2011 0.92
70 Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plast Surg 2005 0.92
71 Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo. J Am Acad Dermatol 2004 0.92
72 Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002 0.92
73 Cutaneous manifestations of Crohn's disease, its spectrum, and its pathogenesis: intracellular consensus bacterial 16S rRNA is associated with the gastrointestinal but not the cutaneous manifestations of Crohn's disease. Hum Pathol 2003 0.91
74 The dermal-based borderline melanocytic tumor: a categorical approach. J Am Acad Dermatol 2010 0.91
75 Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol 2014 0.91
76 Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Mod Pathol 2004 0.91
77 Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg 2004 0.91
78 Immunologic escape and angiogenesis in human malignant melanoma. J Am Acad Dermatol 2003 0.90
79 Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 2013 0.90
80 Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features. J Cutan Pathol 2007 0.89
81 Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol 2003 0.88
82 Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol 2010 0.88
83 Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials. Am J Clin Pathol 2010 0.88
84 Low-risk and high-risk histologic features in conjunctival primary acquired melanosis with atypia: Clinicopathologic analysis of 29 cases. Am J Surg Pathol 2007 0.88
85 Facial nerve hemangiomas: vascular tumors or malformations? Otolaryngol Head Neck Surg 2010 0.88
86 Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis 2012 0.87
87 Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Oncol Rep 2007 0.87
88 Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med 2008 0.87
89 In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections. J Am Acad Dermatol 2002 0.86
90 Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. Methods Mol Biol 2014 0.86
91 Extensive neurocristic hamartoma with skeletal muscle involvement. J Cutan Pathol 2007 0.85
92 Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008 0.85
93 Treatment of synchronous mucinous carcinoma and endocrine mucin-producing sweat gland carcinoma with Mohs' micrographic surgery. Dermatol Surg 2005 0.85
94 An automated image processing method to quantify collagen fibre organization within cutaneous scar tissue. Exp Dermatol 2014 0.84
95 Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol 2004 0.84
96 The molecular basis of melanomagenesis and the metastatic phenotype. Semin Oncol 2007 0.84
97 A nonepidermal, primary malignant melanoma arising in a giant congenital melanocytic nevus 40 years after partial surgical removal. J Am Acad Dermatol 2004 0.84
98 Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol 2012 0.83
99 Biomarkers in melanoma: stage III and IV disease. Expert Rev Mol Diagn 2005 0.83
100 Tracking of second primary melanomas in vemurafenib-treated patients. JAMA Dermatol 2013 0.83
101 Histologically challenging melanocytic tumors referred to a tertiary care pigmented lesion clinic. J Am Acad Dermatol 2012 0.83
102 Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways. Lasers Surg Med 2014 0.82
103 Pathology of malignant melanoma. Surg Clin North Am 2003 0.82
104 Autoantibodies to melanocytes and characterization of melanophages in patients affected by a new variant of endemic pemphigus foliaceus. J Cutan Pathol 2011 0.82
105 Diagnosis and management of nevi and cutaneous melanoma in infants and children. Clin Dermatol 2002 0.82
106 Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol 2002 0.82
107 Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer 2009 0.81
108 The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death. Cancer 2009 0.81
109 Mechanisms of metastasis: seed and soil. Cancer Treat Res 2007 0.81
110 Pigmented epithelioid melanocytoma with lymph node metastasis in a patient with uncontrolled atopic dermatitis. J Dermatol 2014 0.81
111 Histopathology of vascular anomalies. Facial Plast Surg 2012 0.81
112 Biomarkers in melanoma: staging, prognosis and detection of early metastases. Expert Rev Mol Diagn 2003 0.81
113 Malignant basomelanocytic tumor manifesting as metastatic melanoma. Am J Surg Pathol 2004 0.80
114 Biomarkers in melanoma: predisposition, screening and diagnosis. Expert Rev Mol Diagn 2003 0.80
115 Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas. Am J Dermatopathol 2010 0.79
116 Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus. Mod Pathol 2005 0.79
117 Micro-mechanical fractional skin rejuvenation. Plast Reconstr Surg 2013 0.79
118 The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: A distinct form of dysplastic Spitzoid nevomelanocytic proliferation. J Am Acad Dermatol 2009 0.79
119 Combined basal cell carcinoma and Langerhans cell histiocytosis of the scrotum in a patient with occupational exposure to coal tar and dust. Int J Dermatol 2004 0.78
120 Microphthalmia transcription factor expression in cutaneous mast cell disease. Am J Dermatopathol 2002 0.78
121 Compound melanocytic nevi with granular cell changes. J Am Acad Dermatol 2004 0.78
122 In vivo reflectance-mode confocal scanning laser microscopy in dermatology. Adv Dermatol 2004 0.78
123 Lymphatic invasion predicts aggressive behavior in melanocytic tumors of uncertain malignant potential (MELTUMP). Am J Surg Pathol 2013 0.78
124 Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas. Melanoma Res 2016 0.77
125 How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death. Cancer 2009 0.77
126 The precursors of malignant melanoma. Recent Results Cancer Res 2002 0.77
127 Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease. J Am Acad Dermatol 2006 0.77
128 Long-term outcome of Spitz-type melanocytic tumors. Arch Dermatol 2011 0.77
129 Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ. Mod Pathol 2005 0.77
130 CXCR4 pathway associated with family history of melanoma. Cancer Causes Control 2013 0.76
131 CD45/CD8 Myeloid Histioid Antigen and Plasma Cell Antibody Immune Response in a Case of Malignant Melanoma. N Am J Med Sci 2012 0.75
132 What are the clinicopathologic features of matricoma? Am J Dermatopathol 2003 0.75
133 Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am J Surg Pathol 2002 0.75
134 A Hyalinized Trichilemmoma of the Eyelid in a Teenager. Ophthal Plast Reconstr Surg 2016 0.75
135 A 44-year-old woman with right ankle pain. Arthritis Care Res (Hoboken) 2010 0.75
136 Malignant neurocristic hamartoma: a tumor distinct from conventional melanoma and malignant blue nevus. Am J Surg Pathol 2011 0.75
137 Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists. J Am Acad Dermatol 2010 0.75
138 Effects of non-invasive, 1,210 nm laser exposure on adipose tissue: results of a human pilot study. Lasers Surg Med 2009 0.75
139 Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing breslow depth and ulceration. Am J Dermatopathol 2007 0.75
140 Coexistence of diffuse reactive angioendotheliomatosis and neutrophilic dermatosis heralding primary antiphospholipid syndrome. Acta Derm Venereol 2008 0.75
141 Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2B. Am J Clin Oncol 2002 0.75
142 Malignant melanoma arising in a sebaceous nevus of the scalp. Br J Plast Surg 2003 0.75
143 A carcinoma with features of porocarcinoma, dermal ductular carcinoma, and squamous cell carcinoma in situ. Am J Dermatopathol 2007 0.75
144 Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Treat Options Oncol 2006 0.75
145 Use of Photodynamic Therapy and Sterile Water to Target Adipose Tissue. Dermatol Surg 2015 0.75